Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
90 Cards in this Set
- Front
- Back
What are the types of symmetric neuropathies of DM?
|
1) Distal, primary sensory polyneuropathy (can be either mainly marge fibers, small fibers or mixed)
2) Autonomic neuropathy 3) chronic evolving proximal motor neuropathy often caused by osmotic pressure on then nerves from the hyperglycemia / sorbitol / polyol damage ex1: foot with cocked toes due to loss of motor fc in the extensors > flexors --> ulcer under foot due to no sensation = most common from is this mixed kind; ex2: autonomic destruction leads to the sudden death in DM because the warning signs of an MI are missing - also no sensation of the angina... |
|
What are the types of asymmetric neuropathies of DM?
|
1) Acute or subacute proximal motor neuropathy
2) cranial mononeuropathy 3) Truncal neuropathy 4) Entrapment neuropathy in the limbs mechanism is mostly ischemic damage due to blockage of vasa vasorum, so there is often PAIN first and then dysfct: ex1: wrist drop after falling asleep on arm: radial nerve damage = mononeuritis simplex ex2: CN3 palsy causing double vision and unability to look up; but the pupils REACT, because that's regulated by parasympathetic - which runs on the inside of then nerve closest to the blood vessel - is it's affected last = mononeuritis simplex ex3: atrophy of all the hamstring muscles = Amyotrophy - diabetic myopathy - misnomer bc it's the nerve, not the muscle; this is Mononeuritis multiplex |
|
Sulfonylurea
|
long acting Secretagogue
for basal glucose control blocking the K+ channel causes depolarization --> Ca channel opening --> inceased Ca in cell causes release of Insulin SE: problem is: Hypoglycemia (you have to eat because you're constantly emitting insulin) SE: weight gain, SIADH depends on the presence of b-cells |
|
Repaglinide, Nateglinide
|
short acting secretagoges
for post-prandial control of glucose blocking the K+ channel causes depolarization --> Ca channel opening --> inceased Ca in cell causes release of Insulin SE: problem is: Hypoglycemia (you have to eat because you're constantly emitting insulin) SE: weight gain, SIADH |
|
Biguanide
|
Metformin
activation of AMP-Kinase --> signals that we have apparently "low energy" so we get increased fatty acid oxidation and hepatic glucose production as well as decreased glycolysis and more muscle uptake. SE: problem is: Patients with heart conditions or chronic liver disease, or lung disease --> increased risk of lactic acidosis SE: Lactic acidosis, weight loss, Diarrhea |
|
Thiazolidinediones
|
TZD's = insulin sensitizers
Rosiglitazone, Pioglitazone nuclear receptor PPAR-y activation -- more gene activation for insulin production act primarily on adipose cells and secondarily sensitize muscle cells to insulin. (Lipodystrophy study moved fat from the wrong places = inside the organs, to the right places) Side effect: Heart failure!, weight gain |
|
a-glucosidase inhibitors
|
Acarbose, Mitigol
inhibit the absorption of carbohydrates by inhibiting the breakdown to glucose --> malabsorption for post-prandial hyperglycemia SE: some weight loss, but flatulence |
|
intensive DM therapy
|
must be multifactorial - treating all risk factors such as high LDL, HTN, body fat (provides 50% increased risk reduction)
The A1c control eventually reaches the same lvl as the conventional and the slope of increase is the same too - due to loss of beta cells BUT at least we can prevent to microvascular complications (not necessarily what they die from) BUT even after 10yrs later, we still have benefit from the tight glucose control: still have less mortality from CV |
|
Diabetes diet
|
calories from
30% fat - better saturated 50% carbs - better complex ones 15% protein low salt type II DM is same, just also includes calorie reduction overall |
|
before we do pharmacotherapy with DM, what do we order
|
Exercise and Weight loss
|
|
GLP-1 analog
|
GLP-1 analog: the spit from the dragon gives us Exanatide® which is an incretin. These are substances secreted in the anticipation of getting a meal – act on pancreas to secrete insulin
DM have blunting of GLP-1 |
|
Amylin
|
Pramlintide (tradename)
synergizes with insulin |
|
types of insulin
|
Lispro/Aspart = fast acting (fish insulin - only 2 aa different from human, but faster action)
NPH = neutral protamine hagedorn = intermediate acting Lente and Ultralente = long acting Glargine = ultra-long acting; peak-LESS insulin, prevents DKA |
|
autonomic neuropathy in DM examples
|
Cardiovascular: orthostatic hypotension, tachycardia, sudden death
Gastroparesis (devestating, can't dose insulin well) Erectile dysfunction Cystopathy (large post-void residual - ifections) Sudomotor disorders Hypoglycemia unawareness (sweats and others are missing) |
|
erectile dysfunction in DM
|
not purely neuropathic, it's a marker for CV disease
|
|
Sildenafil
|
PDE-5 inhibitor --> constant cGMP increase --> dialate blood vessels in penis
least effective in DM because they don't have a pure neuropathy or a pure vasculopathy (if it were pure n or v, sildenafil might be able to overcome the it) but still 1/3 are helped |
|
valsalva with DM?
|
deep breath, strain
breath normal test finds the changes in the puls and respiration --> changes in sympathetic and parasympathetic normally you should get sinus arrhyhmia with HR changes DM loose this: they'll have a relatively constant pulse do this bc: autonomic NS loss causes sudden cardiac death in DM! |
|
skin findings in DM
|
1) 50-60% will get diabetic dermopathy
past - bad control of DM 2) Necrobiosis lipodica diabeticor - infarction of the fat under the skin |
|
strategies to reduce microvascular complications
why? how? |
prevention is proven to work by intervetion on:
hyperglycemia hypertension treatments proven by intervention trials: -ACE inhibitiors for neuropathy -Laser photocoagulation for retinopathy |
|
what are the macrovascular complications of DM
|
Angina, exercise intolerance (if ANS neuropathy - silent) ---> CAD (2-3x higher; 4x higher risk of dying during MI; 2x higher risk of dying post-MI, also higher risks in Impaired Fasting Glucose pt)
Claudication ---> PVD TIA's, strokes --> CVA Renal artery sclerosis ---> renal failure |
|
Risk of MI in people with DM and without
|
risk of MI in DM if you've never had an MI = same as risk of non-DM who's had an MI
same in several ethnic populations |
|
what causes the increased CVD in DM?
|
hyperclycemia: as it increases, the risk increases
even before HA1c is before 6 it increaes the risk - so even though in the nl population without DM |
|
pattern of DM dyslipidemia
|
increased fraction of small, dense LDL-cholesterol (without increase in total quantitiy of LDL-C) - more atherogenic
high TG (independent strong risk factor proven only for DM) low HDL Postprandial lipemia (free FA are high in DM persistently) |
|
pathophys of macro-vasc dz in DM
|
"AGE" of endothelial proteins
HTN accelerated artheroscleros Dyslipidemia (peculiar type) |
|
prevention of macrovascular complications
|
Consider:
HTN Hyperglycemia Obesity Cigarrette smoking Dyslipidemia Altered coagulation, platelet fct, fibrinosis, Nephropathy Insulin resistance |
|
early and aggressive tx to reduce macrovascular complications
|
dyslipidemia
HTN anti-platelet (not proven yet - thrombolysis, endothelial disorders) |
|
skin finding from severe dyslipidemia
|
Eruptive Xanthomas - look like red bumps = blobs of VLDL
|
|
normally, how do we break TG
changes with insulin type I? |
hormone sensitive lipase(HSL) turns the TG into FFA and ships it to the liver --> makes more ApoB, VLDL, TG --> VLDL is released and transported to fat cells and LPL turns it into fat; (LPL prevents the conversion of VLDL into IDL -- LDL)
Changes in DM I: 1) Insulin stops HSL and activates LPL --> greater influx of FFA to liver ---> more VLDL also the VLDL is not taken up by the fat cells --------> shunting to IDL and LDL 2) CETP = cholesterol transporter protein is increased in DM: a)it moves cholesterol from LDL into VLDL and it and moves TG from VLDL into LDL --> we get a small LDL b) moves cholesterol from HDL to VLDL, and TG from VLDL to HDL ---> depletes VLDL of TG and depletes HDL/LDL of cholesterol THIS is the reason for "low HDL" "nl LDL" because they measure the cholersterol in there - however these modified lipid particles are more artherogenic |
|
management of Dyslipidemia
|
ATP III diet for metabolic syndrome
Hyper-TG / low HDL-C: Niacin (blocks release of FA), Fibrates(activates the oxidization of FA) LDL-C: statins Combinations (beware of rhabdomyolysis -- renal disease) |
|
what type of obesity is worse?
fat location |
apple shaped - MALE pattern of putting on fat is worse
= the central fat is more toxic (means more visceral obesity ---> higher TG, higher cholesterol, lower HDL, more insulin resistance) pear shaped - women is better |
|
management of AMI in DM
|
b-blockers
ASA ACE inhib Angiopasty vs bypass ?? angioplasty might be worse for DM Glucose control even in hospital: -continuous intravenous insulin -followed by intensive glucose control |
|
"HONK"
|
HHNS
extreme hyperglycemia -poorly treated/undetected DM -renal insufficiency -age/mental obtundation -> decreased oral fluids absence of ketosis -insulin is not totally deficient severe dehydration and volume depletion coexisting chronic illnesses high mortality |
|
what should you calculate with HONK presentation
|
effective osmolariy
2(Na) + glucose/18 + BUN/2.8 if it's over 300 --> person is hyperosmolar (must be there if you want to diagnose HONK) important bc > 330 greatly increases the risk for seizures and increased mental obtundation |
|
HHNS treatment
|
Isotonic and hypotonic fluids (unlike DKA, where the main problem is isotonic loss with some degree of free water loss, in HONK it's a mix of both - with tremendous hypovolemia + tremendous dehydration)
(first enough volume, till pressure is restored - and then start giving water to correct the Na) MONITOR electrolyte replacement Insulin (no longer on top) Treatment |
|
difference btw dehydration and hypovolemia
|
loss of salt and water in nl proportion = hypovolemia; no good blood tests - Na is variable;
(BP, skin turgur, urine output) loss of water alone = dehydration; plasma Na is high |
|
Lactic acidosis
why is DM more prone? causes? type? |
normal healthy persion will have LA <1
well controlled DM has higher baseline >1 DM more prone, also bc tendency of vascular disease and also bc drugs for DM can cause this CAUSES (2) Lack of Oxygen or a Toxin that prevents the pyruvate dehydrogenase shunt to the krebs cycle: Types (2) with hypoxemia/shock(type A) without hypoxemia/shock (typeB) -illnesses -toxins -hereditary -miscellaneous |
|
what contributes to lactic acidosis in DM?
|
Hypotension (acute GI hemorrhage, sepsis, pancreatits)
Arterial oxygen desaturation Decreased Cardiac output Regional hypoperfusion Drugs (Metformin) |
|
biochemical basis of lactic acidosis
|
Glycolysis supplies ATP but requires NAD
Pyruvate to Lactate sustains the cycle because it yields fresh NAD self-sustaining |
|
treatment of lactic acidosis
|
1) correct hypoxia
2) remove toxins bicarbonate (caution because more CO2 --> pH more acidic if you can't blow it off) dichloroacetate (for one condition in children - shunts more oxygen down ) |
|
serious complications of DM
|
retinopathy
nephropathy (leading cause of ESRD) neuropathy (feet hurt like hell, ED, paresthesias..) stroke CVD |
|
Retinopathy
causes |
can be traced to a glucose alone phenomenon - more than the others
increased polyol accumulation --> deminishes myo-inositol formation of AGE's - becomes a problem if glucose sticks to a protein that makes up the BM of a vessel -- makes blidness increased oxygen stress increased protein kinase C - beta activity = leakage of vessel |
|
Polypol pathway
|
D-glucose -- sorbitol -- fructose
more sorbitol = it's more poorely metabolized and so it sits there and causes osmosis --> swelling |
|
AGE's
where from? Shiff base... |
Shiff base still reversible, but then Amadori product --- further products
if Hg is glycosylated it's that way for ever- till the RBC dies - A1c is that - so it's used to measure |
|
eye disease in DM
frequency stages 3causes of blindness in DM |
1/2 of all DM
incidence is not parallel to nephropathy - it flattens out after 25y Stages -Background - microaneurisms, dot-blot hemorhage, hard exudates(white) -pre-prolif: soft exudates, IRMA, large hemorrhage -Proliferative - hypoxia causes Neovascularization (= key for prevention of blindness) [increased endothelial cells and less pericytes cause leaky vessels and hypoxia --> VEGF/PKC --> angiogenesis , vitreal and retinal] circinate exudates = warning of impending macular edema [ other cause of blindness besides neovascularization and bleeding ] - before they get angio pre-retinal hemorrhage - serous complication of proliferative retinop chronic complications of neovasc after bleed-- vitreus pulls on retina - |
|
laser ablation of which vessels?
photo-coagulation |
pan-retinal laser destroys the vessels on the periphery and leaves the center of the macula; central area is clean
this is supposed to shunt the blood to the right areas, preventing blindnes |
|
Rubeosis iridis
|
neovascularization of the IRIS
|
|
glycemic control and retinopathy
DCCT |
trial convinced us that
intensive glucose Rx reduced development of retinopathy - the microvascular complications at least with the glucose control + eye doctor |
|
kidney disease in DM
|
very high morbidity and mortality type 1 > type 2
distinct susceptibility genes -Na/H pump overexpression -ethnic differences -simpling pair analysis |
|
natural Hx of kidney disease
MEMORIZE THIS |
larger kidney - GFR higher
(increased pressure is actually bad) creatinine is great in the silent period but if you dont' do anything, the'll get proteinuria, azotemia and then ESRD 3yrs prior to onset of DM: -GFR 120, creat 1, ureaN 15 onset of DM -GFR 150, creat 0.8, ureaN 10 3yrs post onset: Diabetic Glomerulosclerosis -GFR 150, creat 0.8, ureaN 10 MICROALBUMINURIA (earliest sign - seen in the silent period - test: must be able to find low lvl of albumin - here we can still slow it down) -15yrs post onset of DN: time of silent period is over: onset of proteinuria -GFR 120, creat 1, ureaN 15 20yrs post onsetDM: Azotemia -GFR 60, creat >2, ureaN >30 23yrs post onset DM: ESRD -GFR <10, creat >10, ureaN >110 |
|
renal changes in DM
|
1) renal hyperfiltration
2) renal lesions without clinical signs (microalbuminuria) 3) Nephropathy (microalbuminuria) Kippel-wilson 4) ESRD Focal glomerulosclerosis |
|
hemodialysis
|
only prolongs life by another 5-6yrs
|
|
Albuminuria
|
normal <20
Microaluminuria 30mg - 300 / 24h Macroalbuminuria >300 - increased risk for renal disease and macrovascular disease so microalbumin is almost as impotant as a signal as high LDL for risk of MI |
|
why ACE - I?
cant give to? |
in addition to glycemic control, for nephrotic prevention:
ACE-I because the pressure must be dropped by releasing the efferent constriction BUT we can't give it to sb who already has afferent disease because they won't have enough flow to the kidney at all |
|
proximal/afferent vascular disease?
|
put them on a small dose of the ACE-I
if the creatinine goes up - you know you can't use up because they already have afferent arterioal disese |
|
most common chronic complication of DM
pathology? |
nervous system dysfunction
ex: ED sensory, motor, cranial, autonomic Types: Symmetric is most common Asymmetric Radiculopathy Autonomic Pathology: distal, multiple neuropathies -- usually polyol pathway proximal, mononeuropathies usually vascular |
|
Parent or Sibling with DM what's worse?
for DM type I ? and for DM type 2? |
For DM I it's higher risk if sibling had it
For DM II it's higher if parents had it (45% if they both had onset <50; identical twin 60%) |
|
MODY
type of defect? |
maturity onset diabetes of youth
type II DM the genes associated with each of the MODY syndromes is mostly to do with the insulin secretion rather than insulin action; so they're b-cell defects startling, because the whole time we thought that DM type II was a problem of insulin action - not a destruction of the b-cells ( = type I); but apparently the MODY's are type II because they don't need that much insulin |
|
Calpain-10, TCF7-L2
|
genes that are part of the group that cause the common DM type II
polygenetic - common forms of DMII are still functions of the b-cell!! |
|
Glucokinase
mutation? |
Glucose is converted to Glucose-6P
this is the beginning of the glucose breakdown to ATP which eventually tells the cells that they need to make insulin; it's sometimes called the insulin sensor because of that MODY-2 has a mutation in this they have a higher "set point" because they're not effectively sensing the glucose --> they'll have a mild stable hyperglycemia - they have an altered setpoint |
|
2 principles of type 2 DM
2 starting points --- >>> |
Insulin resistance + b-cell dysfunction
(+ environment) I I I I Inpaired Glucose TOlerance I Type II DM from this further Gluco-/Lipo- Toxicity leads to more insulin resistance and more b-cell dysfunction often not detected till it's type 2 and it's already in the vicious cycle |
|
stages of type II DM
path to the development of DM |
Peripheral insulin resistance (high insulin) / b-cell dysfunction ---> Impaired glucose tolerance ---> early b-cell damage --> early DM --> late bcell damage --> late DM
|
|
5 acute complications of DM
|
Insulin-induced hypoglycemia
DKA Hyperosmolar hyperglycemic nonketotic state (HONK) Lactic acidosis |
|
Hypoglycemic reactions
2 types |
Neurogenic: (Sympathetic and parasympathetic activation)
-sweating -hungry -tingling -shaky -heart pounding -nervous/anxious neuroglycopenic (CNS symptoms): -warm -weak -difficulty in thinking -tired / drowsy -faint -dizzy -difficulty speaking -blurred vision these are to be considered separately because they have different thresholds - usually you get the autonomic sx first; however, DM pt with neurpathic damage might loose the neurogenic signs and the first presentation is the seizure |
|
insulin injection
|
release of Epi (very high) and Ne fast
little bit later glucagon cortisol GH |
|
DKAhave to have all 3:
|
hyperglycemia: osmotic diuresis, volume depletion, dehydration
ketoacidosis: anion-gap acidosis other metablic changes |
|
how do we get DKA
K: the ketones |
adipocyte release FFA
the controls is via insulin/glucagon ratio Liver turns the FFA into Ketone bodies or TG; The production into Ketone is also under control of: insulin/glucagon ratio high insulin and low glucagon prevent the DKA - so the DM pt has a perfect set up: decreased insulin --> lipolysis --> FFA to liver + increased glucagon --> increased hepatic carnitine content/decreased malonyl CoA : so now the FFA can get into the mitochondria--> activation of CAT --> accelerated ketones both together cause the ketones |
|
reason for tipping to DKA
|
historical: they're type I and something that tipped it over:
-alcohol, drugs, infection , MI/stroke, trauma, pregnancy, didn't take their insulin but now we know: Blacks and Hispanics have almost equal chance of being type I or type II phenotype when they are found w/ DKA; so now we consider: "Ketosis - prone - DM" KPD |
|
DKA: D: hyperglycemia
cause: effects: |
hyperglycemia
cause: insulin deficiency, leading to increased hepatic glucose production decreased peripheral glucose utilization effect: -osmotic effect: water pulled from ICF to ECF, osmotic diuresis -ECF volume: -Renal loss of water > electrolytes volume depletion some degree of dehydration |
|
DKA: A: metabolic acidosis
cause: effects: |
cause:
-xs acetoacetic acid and b-OH butyric acid production -deminished renal excretion of H+ effect: -H+ HCO- ---- H2CO3 -- CO2 H2O ultimate correction of H+ xs depends on: oxidation of AAA + bOHB, renal excretion of H+ -exchange of H+ for Na -anemia --> ammonium loss of electrolytes in urine |
|
water and electrolyte imbalance in DKA
|
cause:
-osmotic diuresis -vomiting -increased aldo -ICF - ECF shift (K+ PO4) effect: -10% body weight loss as fluid!! 50% extracell, 50% intra -loss of: K+, Na+, PO4- |
|
symptons of DKA
|
N/V
polyuria/polydipsia abdominal pains mental changes (leathery to near-coma) signs: -fruity breath (due to acetone) -Kussmaul respirations (rapid, deep breaths pH7.2 or less) -signs of volume depletion (tachycardia, orthostatic hypoTN) -sings related to precipitating factors (infection , MI, trauma) |
|
Labs of DKA
|
elevated blood glucose
pH < 7.35 low HCO3- high anion gap positive serum ketones |
|
calculation of corrected Na concentration
|
you expect them to be hypernatremic bc. so much water loss, but the pt is often "hyponatremic" when you see them : artificially bc glucose is sucking water in the blood;
tells you what the pt would have been without the glucose Na + 1.6 (glucose - 100) / 100 |
|
Anion Gap
|
Na - (Cl + HCO3) = 8-12 (+/-2 )
if it's 14, it's already enough check if it's complex or simple |
|
DKA treatment
order |
Isotonic fluids
Insulin potassium Monitor treat precipitating cause |
|
who get's HONK
|
older folks who don't have
typical type I DM not a complete lack of insulin it's like DKA without ketones the glucose will be like 900!!! they have other things that prevent them from drinking... |
|
Besides type I or II what other conditions could you classify the diabetic as?
|
Cushings disease - pituitary adenoma
Obesity Addisons (autoimmune disorder, as is DM I, also check thyroiditis pt for this) Drug or chemical induced Turners Klinefelters X-linked insulin receptor mutation Gestational DM |
|
Gestational DM
|
induces insulin resistance
2-13% of pregnant women get DM (higher in AA < asian ) , usually 2nd - 3rd trimester GDM is associated with increased fetal and materal morbidity xs morbidity can be reased by maintaining normoglycemia: increase in insulin production to compensate for the insulin resistance; you can also give her insulin diagnostic criteria by OGTT; very strict - lower than non-preg; after delivery, risk of type II is 30-40% in 10yrs |
|
risk of getting type I DM
a) no Fhx b) father with type I c) mother with type I; <25yo @ child birth d) mother with type I > 25yo e) sibling |
a) 1%
b) 6% c) 4% d) 1% sibling 5-10% 2 relatives 20% identical twin 25-50% |
|
autoimmune type I DM
genes |
HLA DQA1, B1, B1 ((chromosome 6)
cytokines T-cell b-cell: insulin |
|
environmental triggers of autoimmune DM
|
coxackie,
milk |
|
markers for type I DM
|
GAD antibodies - glutamic acid decraboxylase antibodies
antibodies against IA-2 (b-cell phosphatase) antibodies against ZnT8 antibodies against Insulin serum from the pt looking for Igs fluorescence the titers rise years before the onset of DM (is this the incubation period?) |
|
progression of DM type I
|
genetic predisposition
immunologic abnomalities progressive impairment in insulin release presentation at doctor 80% loss of b-cells give insulin --> honeymoon period but then overt DM |
|
Risks for type II DM
|
Native american > mexican > african americans > caucasians
obesity metabolic syndrome (IGT/IFG)[low HDL, high LDL, HTN, waist cicrumference] environment (sedentary, fast food) |
|
factors progressing IGT to type 2 DM
|
insulin resistance / hyperinsulenmia
central obesity hyerTG HDL <35 HTN family x Hx of gestational DM |
|
inputs into/causing: Insulin resistance
outputs? |
Aging, medications (steroids, b-blockers), Fat cell defects, obesity and inactivity, genetic abnormalities, type 2 DM
----> hypertension, Dyslipidemia, Atherosclerosis, PCOS as long as the b-cell is ok, this will still not give you DM - but if it starts dying... |
|
changes in insulin secretion, glucose disposal and blood glucose
|
normal person has high normal insulin with high glucose excretion
obese pt has higher insulin and lower glucose excretion IGT pt has peak insulin and lowest glucose excretion "here the pancreas is still trying to compensate for the insulin resistance by making more insulin, but then it gives up: ..." early diabetic has low insulin and still lowest glucose excretion late DM - insulin down and so is gluc excretion pancreas is failed at the very end, the type II DM becomes a type I DM |
|
DM skin
|
acanthosis nigircans
|
|
diagnostic criteria for diabetes
|
symptoms + random plasma glucose >200
or FG >125 (= 126 or higher) or OGTT > 200 |
|
diagnostic criteria for impaired glucose tolerance
|
FG: >100 - 125
OGTT 140 - 200 |